Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16070703 | PS47 | 1180676-33-8 | 98% by HPLC |  |
| PS47 | ||||
| 16062804 | PIK-293 | 900185-01-5 | 98% by HPLC |  |
| PIK-293 is a PI3K inhibitor | ||||
| 16062108 | 5-pyridin-4-yl-2,4-dihydro-3H-1,2,4-triazole-3-thione | 1477-24-3 | 98% by HPLC |  |
| 5-PYRIDIN-4-YL-4H-[1,2,4]TRIAZOLE-3-THIOL | ||||
| 16060702 | Paritaprevir | 1216941-48-8 | 98% by HPLC |  |
| Paritaprevir, also known as ABT-450, is an acylsulfonamide inhibitor of the NS3-4A se | ||||
| 16053002 | PXD-101 | 866323-14-0 | 98% by HPLC |  |
| Belinostat (trade name Beleodaq, previously known as PXD101) is a histone deacetylase | ||||
| 032501 | PS-1145 | 431898-65-6 | 98% |  |
| Coming soon! | ||||
| 032407 | 2-Pyridinemethanamine, N-[2-(diphenylphosphino)ethyl]- | 1388712-98-8 | 98% | ethyl]--cas-1388712-98-8.png) |
| Coming soon! | ||||
| 020202 | PF-06424439 | 1469284-78-3 | 98% |  |
| PF-06424439 is a potent and selective Diacylglycerol Acyltransferase 2 ( DGAT2) inhib | ||||
| 020201 | PF-06471553 | 1808094-07-6 | 98% |  |
| PF-06471553 is a potent and selective Monoacylglycerol acyltransferase 3 (MGAT3) inhi | ||||
| 020102 | PF-06282999 | 1435467-37-0 | 98% by HPLC |  |
| PF-06282999 is an irreversible inactivator of myeloperoxidase, and currently in clini | ||||
| 020101 | PF-3274167 | 900510-03-4 | 98% |  |
| PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki | ||||
| 012011 | Pifithrin-alpha | 63208-82-2 | 98% |  |
| Pifithrin- is an inhibitor of p53, inhibiting p53-dependent transactivation of p53-re | ||||
| 012008 | PF-04880594 | 1111636-35-1 | 98% |  |
| PF-04880594 is a RAF inhibitor, which induces ERK phosphorylation and RAF dimerizatio | ||||
| 012006 | PF-2545920 | 898562-94-2 | 98% |  |
| PF-2545920 is a phosphodiesterase inhibitor selective for the PDE10A subtype, which i | ||||
| 011119 | Pyriofenone | 688046-61-9 | 98% |  |
| Coming soon! | ||||
| 011105 | PF-03814735 | 942487-16-3 | 98% |  |
| PF-03814735 is an orally bioavailable, ATP-competitive, reversible small-molecule Aur | ||||
| 010821 | PND-1186 | 1061353-68-1 | 98% |  |
| PND-1186 is a potent FAK inhibitor with a 50% inhibitory concentration of 1.5 nM in v | ||||
| 010807 | PF-04217903 | 956905-27-4 | 98% |  |
| PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM, susce | ||||
| 010423 | PF-5274857 | 1373615-35-0 | 98% |  |
| PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog ( | ||||
| 010416 | Progesterone | 57-83-0 | 98% |  |
| Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregna | ||||
| 010415 | Pravadoline | 92623-83-1 | 98% |  |
| Coming soon! | ||||
| 010414 | PD318088 | 391210-00-7 | 98% |  |
| PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binds simultaneously w | ||||
| 123020 | PF-04691502 | 1013101-36-4 | 98% |  |
| PF-04691502 is an ATP-competitive PI3K(///)/mTOR dual inhibitor with Ki of 1.8 nM/2.1 | ||||
| 123013 | PKC412 | 120685-11-2 | 98% |  |
| PKC412 is a broad spectrum protein kinase inhibitor; inhibits conventional PKC isofor | ||||
| 123004 | Plerixafor octahydrochloride | 155148-31-5 | 98% |  |
| Plerixafor octahydrochloride is a chemokine receptor antagonist for CXCR4 and CXCL12- | ||||
| 122950 | PF-3084014 | 1290543-63-3 | 98% |  |
| PF-3084014 is a novel -secretase inhibitor that reduces amyloid-beta (Abeta) producti | ||||
| 122941 | Pacritinib ( SB1518 ) | 937272-79-2 | ≧98.0% | _937272-79-2.png) |
| Pacritinib(SB1518) is a highly selective kinaseinhibitorwith specificity for JAK2, FL | ||||
| 122916 | PHA-848125 | 802539-81-7 | 98% |  |
| PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM; &g | ||||
| 122908 | PI-3065 | 955977-50-1 | 98% |  |
| PI-3065 is a novel potent and selective PI3K p110 inhibitor with IC50 of 15 nM; exhib | ||||
| 122903 | PD 123319 | 130663-39-7 | 98% |  |
| PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of | ||||